Current and future therapeutics targeting mast cells in disease
Open Access
- 30 May 2025
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 273, 108892
Abstract
No abstract availableKeywords
Funding Information
- H2020 European Research Council (ERC-2021-CoG 101043749)
- European Research Council
- Agence Nationale de la Recherche (ANR-20-CE15-0026)
- Agence Nationale de la Recherche (ANR-24-CE18-6970)
- Fondation ARC pour la Recherche sur le Cancer
This publication has 221 references indexed in Scilit:
- Mast Cell–Targeting Therapies in Mast Cell Activation SyndromesCurrent Allergy and Asthma Reports, 2024
- Elevated, FcεRI-Dependent MRGPRX2 Expression on Basophils in Chronic UrticariaSkin Health and Disease, 2022
- The international consensus classification of mastocytosis and related entitiesVirchows Archiv, 2022
- Ligelizumab treatment for severe asthma: learnings from the clinical development programmeClinical & Translational Immunology, 2021
- Ligands and Signaling of Mas-Related G Protein-Coupled Receptor-X2 in Mast Cell Activation2020
- Novel MRGPRX2 antagonists inhibit IgE-independent activation of human umbilical cord blood-derived mast cellsJournal of Leukocyte Biology, 2019
- Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophilsJournal of Leukocyte Biology, 2018
- IgE and mast cells in host defense against parasites and venomsSeminars in Immunopathology, 2016
- Histamine synthesis is required for granule maturation in murine mast cellsEuropean Journal of Immunology, 2013
- Role of c-kit in mammalian spermatogenesisJournal of Endocrinological Investigation, 2000